248 related articles for article (PubMed ID: 21220322)
21. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
[TBL] [Abstract][Full Text] [Related]
22. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
23. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.
Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420
[TBL] [Abstract][Full Text] [Related]
24. Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.
Perez S; Fishman S; Bordowitz A; Margalit A; Wong FS; Gross G
Immunology; 2014 Dec; 143(4):609-17. PubMed ID: 24943731
[TBL] [Abstract][Full Text] [Related]
25. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
26. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.
Dai YD; Marrero IG; Gros P; Zaghouani H; Wicker LS; Sercarz EE
Diabetes; 2009 Jan; 58(1):156-64. PubMed ID: 18984740
[TBL] [Abstract][Full Text] [Related]
27. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
28. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
29. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
[TBL] [Abstract][Full Text] [Related]
30. Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells.
Berry G; Waldner H
J Vis Exp; 2013 May; (75):e50389. PubMed ID: 23685789
[TBL] [Abstract][Full Text] [Related]
31. Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat.
Ellerman KE; Like AA
Diabetes; 1999 May; 48(5):975-82. PubMed ID: 10331400
[TBL] [Abstract][Full Text] [Related]
32. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
[TBL] [Abstract][Full Text] [Related]
33. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
34. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
35. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
36. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
37. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
38. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
39. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
40. Antigen presentation in the autoimmune diabetes of the NOD mouse.
Unanue ER
Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
